Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Diseases
Parkinson's Disease
Multiple Sclerosis and Related Disorders
Headache
Amyotrophic Lateral Sclerosis
Epilepsy
Sleep Disorders
Stroke
Neuromuscular Disorders
Movement Disorders
View all Diseases
Topics
Biology
Diagnostics
Trial Updates
Treatment
Prevention
Surgery
Imaging
Genetics
COVID-19
View all Topics
Conferences
EHC 2022
AES 2022
WSC 2022
ECTRIMS 2022
EHDN 2022
MDS 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Amyotrophic Lateral Sclerosis
3:23
The significance of glial cells in the pathophysiology of ALS
Serge Przedborski
• 16 Sep 2022
3:03
Pridopidine application beyond Huntington’s disease
Michael Hayden
• 27 Sep 2022
1:51
Phase II extension trial of CNM-Au8 in ALS
Matthew Kiernan
• 4 Apr 2022
1:49
The pipeline of late-stage therapeutic options for patients with ALS
Matthew Kiernan
• 4 Apr 2022
1:15
An overview of the developments in ALS research
Matthew Kiernan
• 4 Apr 2022
1:47
Important developments in understanding the mechanisms of ALS
Matthew Kiernan
• 4 Apr 2022
1:48
Personalizing therapy: the future of ALS treatment
Nigel Leigh
• 17 Mar 2022
2:53
Developing biomarker panels for ALS diagnosis
Nigel Leigh
• 17 Mar 2022
3:44
Changing our approach to ALS clinical trial design
Nigel Leigh
• 17 Mar 2022
2:13
MIROCALS: low-dosage IL-2 for the treatment of ALS
Nigel Leigh
• 17 Mar 2022
1:58
Assessing the role of measuring plasma neurofilament light levels in ALS
Nigel Leigh
• 17 Mar 2022
1:11
AMD3100 in animal models of ALS and MS
Beka Solomon
• 17 Mar 2022
6:28
Correlation between synaptic density and cognitive issues in ALS
Anna Sanchez Avila
• 8 Mar 2022
4:45
How can the gut microbiome modulate the peripheral and brain immune systems?
Giulio Pasinetti
• 18 Mar 2022
2:44
Improving ALS diagnosis: the Gold Coast criteria and the role of TMS
Matthew Kiernan
• 4 Apr 2022
2:20
Ex vivo gene therapy for neurodegenerative diseases
Clive Svendsen
• 15 Mar 2022
1
2
3
Next